TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
BiolacUm AB
Closing information (x1000 EUR)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
34
|
54 | |
| Financial expenses |
0
|
225 | |
| Earnings before taxes |
188
|
-203 | |
| EBITDA |
13
|
22 | |
| Total assets |
643
|
476 | |
| Current assets |
56
|
54 | |
| Current liabilities |
5
|
4 | |
| Equity capital |
623
|
453 | |
| - share capital |
9
|
9 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
96.9%
|
95.2% | |
| Turnover per employee |
34
|
54 | |
| Profit as a percentage of turnover |
552.9%
|
-375.9% | |
| Return on assets (ROA) |
29.2%
|
4.6% | |
| Current ratio |
1120.0%
|
1350.0% | |
| Return on equity (ROE) |
30.2%
|
-44.8% | |
| Change turnover |
-18
|
-21 | |
| Change turnover % |
-5%
|
-34%
|
-28% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.